Overview
The 2025 DIA Asia Meeting invites you to join an inspiring gathering of regulators, academia, clinicians, patient representatives, and industry leaders from across China, Korea, Japan, Singapore, Southeast Asia, and beyond. This year’s theme, Integrating Clinical Trials into Clinical Practice, highlights the essential role of collaboration and innovation in driving better patient outcomes and transforming healthcare in Asia.
Together, we will explore cutting-edge topics, including:
- Digital Health to Revolutionize Patient Care
- Discover how AI and machine learning are shaping drug development, clinical trial execution, and operational efficiency in healthcare.
- Unlocking the Power of Real-World Data (RWD)
- Learn strategies to address operational and functional challenges, ensuring fit-for-purpose data assets from electronic medical records (EMR), claims, patient registries, genomics data, and more.
- Advancing Precision Medicine
- Discuss breakthroughs in targeted treatments for rare diseases and oncology, transforming care so patients receive the right treatment at the right time.
- Enhancing Regulatory Oversight and Compliance
- Examine the balance between regulatory and ethical oversight and the practical applications of regulatory science in clinical practice.
With deep dives into these pivotal topics, the conference will provide actionable insights into the latest trends in clinical research, AI, digital health and regulatory science, offering a platform to exchange best practices and drive healthcare transformation across the region.
Don’t miss this opportunity to shape the Future of Healthcare in Asia. Join us to gain invaluable knowledge, expand your professional network and collaboration, and prepare for the challenges and opportunities that lie ahead.
Program Committee
-
Jing Ping Yeo, PhD Global Head, Project Operations & Head, Transformation
George Clinical, Singapore -
Yil-Seob Lee, MD, PhD Professor
CHA Bundang Medical Center , Korea, Republic of -
Rie Matsui, RPh Senior Director, Regional Labeling Head for APAC, International Labeling
Pfizer R&D Japan G.K., Japan -
Xiaojun (Wendy) Yan, MD, MBA Senior Vice President, Senior Advisor
BeiGene (Beijing) Co., Ltd., China -
Young Joo Park, PhD, MPH VP, Korea, Singapore, and Southeast Asia
DIA, Korea, Republic of -
Joon-woo Bahn, MD, PhD Professor
Asan Medical Center, Department of Convergence Medicine,, Korea, Republic of -
Endang Wahjuningtyas Hoyaranda President
Indonesian Association for the Student of Medicinals (IASEMD), Indonesia -
Ken Lee EVP
SYNEOS HEALTH SINGAPORE PTE LTD, Singapore
Have an account?